Business Description
Aptahem AB
ISIN : SE0022447173
Total Employee Number:
3Compare
Compare
Traded in other countries / regions
APTA.Sweden94V.Germany IPO Date
2024-06-14Description
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.98 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 56.9 | |||||
3-Year EPS without NRI Growth Rate | 56.5 | |||||
3-Year FCF Growth Rate | 70.3 | |||||
3-Year Book Growth Rate | -50.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.85 | |||||
9-Day RSI | 98.1 | |||||
14-Day RSI | 91.54 | |||||
3-1 Month Momentum % | 1520 | |||||
6-1 Month Momentum % | -7.32 | |||||
12-1 Month Momentum % | -29.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.23 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 0.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -110.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -8.8 | |||||
ROA % | -8.59 | |||||
ROIC % | -8.77 | |||||
3-Year ROIIC % | 20 | |||||
ROC (Joel Greenblatt) % | -6855.63 | |||||
ROCE % | -8.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.21 | |||||
EV-to-EBIT | -2.09 | |||||
EV-to-Forward-EBIT | -1.5 | |||||
EV-to-EBITDA | -2.16 | |||||
EV-to-Forward-Revenue | 8.94 | |||||
EV-to-FCF | -1.98 | |||||
Earnings Yield (Greenblatt) % | -47.85 | |||||
FCF Yield % | -37.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptahem AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.021 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 1527.98 | ||
| 14-Day RSI | 91.54 | ||
| 14-Day ATR (€) | 0.000568 | ||
| 20-Day SMA (€) | 0.07071 | ||
| 12-1 Month Momentum % | -29.87 | ||
| 52-Week Range (€) | 0.004365 - 0.132259 | ||
| Shares Outstanding (Mil) | 25.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptahem AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptahem AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-27 | In 135 days | ||
| Second quarter earnings results for 2026 | 2026-08-27 | In 43 days | ||
| First quarter earnings results for 2026 | 2026-05-28 | 0.07 (+0.00%) | ||
| General meeting for 2026 | 2026-03-27 10:00 | 0.07 (+0.00%) | ||
| Annual report for 2025 | 2026-02-27 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-28 | 0.07 (+4.01%) | ||
| Second quarter earnings results for 2025 | 2025-08-28 | 0.12 (-0.36%) | ||
| General meeting for 2025 | 2025-06-25 11:00 | 0.08 (+6.81%) | ||
| First quarter earnings results for 2025 | 2025-05-22 | 0.07 (-1.19%) |
Show
Entries
Aptahem AB Frequently Asked Questions
What is Aptahem AB(STU:94V)'s stock price today?
The current price of STU:94V is €0.07. The 52 week high of STU:94V is €0.13 and 52 week low is €0.00.
When is next earnings date of Aptahem AB(STU:94V)?
The next earnings date of Aptahem AB(STU:94V) is 2026-08-27.
Does Aptahem AB(STU:94V) pay dividends? If so, how much?
Aptahem AB(STU:94V) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Aptahem AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers